Search

Your search keyword '"Viatris Inc. -- Forecasts and trends"' showing total 9 results

Search Constraints

Start Over You searched for: Descriptor "Viatris Inc. -- Forecasts and trends" Remove constraint Descriptor: "Viatris Inc. -- Forecasts and trends" Journal m2 presswire Remove constraint Journal: m2 presswire
9 results on '"Viatris Inc. -- Forecasts and trends"'

Search Results

1. Night Vision Disturbance Market Size was highest in the US among the 7MM, accounting for ~USD 1,754 Million which is further expected to rise at CAGR of 1.08% by 2034, estimated DelveInsight

2. Bronchial Spasm Market Forecast 2032: FDA, EMA and PDMA Approvals, Epidemiology, Therapies, Companies by DelveInsight

3. Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale

4. Post-Surgical Pain Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, and Forecast by DelveInsight | Novartis, MedinCell, Unither, Esteve, Formosa, Acadia, Teikoku

5. Global Motion Sickness Drugs Market 2022 to 2026: Featuring Aurobindo Pharma, Baxter International, Caleb Pharmaceuticals, Cipla and CVS Health Among Others

6. $4.2 Billion Overactive Bladder Treatment (OAB) Markets - Global Forecasts to 2027: Growing R&D Investments and the Launch of Novel Therapies in the Coming Years

7. Antiparasitic Drugs Global Market Report 2022: Government, Non-Profit and Market Player Initiatives to Boost Adoption Bode Well For Growth

8. The Worldwide Non-steroidal Anti-inflammatory Drugs Industry is Expected to Reach $25.5 Billion by 2028

9. Global Alzheimer's Therapeutics Market Report (2022 to 2032) - Players Include Macleods Pharmaceuticals, Viatris, Lupin and Cipla

Catalog

Books, media, physical & digital resources